Send photos
Photograph the material, nameplates and quantity, then send them through the quote form, by email or by phone.
Pharmaceutical plants cannot lose power for even seconds without losing product. Here is what the industry runs, why, and when those units hit the used market — where Ironcrest buys them.
A pharmaceutical facility is a chain of validated processes — and a power interruption breaks the chain. Clean rooms lose their pressure cascades and contamination control. Cold storage drifts out of its validated temperature range. Production batches in progress can be lost entirely: industry sources describe even a 10–30 second transfer lag as potentially catastrophic in process loss.
Power itself is not directly regulated by the FDA the way manufacturing processes are — but the consequences of losing it are. That is why backup generation is treated as process-critical infrastructure, not just building utilities.
Pharmaceutical standby installations typically range from 100 kVA to 2 MW, sized to the facility’s validated critical load — clean rooms, cold storage, and production lines, not the whole building. Real-world examples from the industry include 500 kVA standby sets for laboratory expansions and paired 100 kVA units in N+1 configuration for biopharma cold storage, so one unit can fail or be serviced without dropping the load.
N+1 redundancy is the common pattern: enough capacity to carry the critical load with one unit out of service, because maintenance windows still have to happen while product is on the line.
Several frameworks push pharmaceutical companies toward serious backup power:
Pharma generators hit the secondary market on a predictable cycle: facility expansions that outgrow existing capacity, utility upgrades that trigger re-validation (often cheaper to replace the generator than re-validate around it), site consolidations, and emissions rules that retire older-tier engines. Because these units run standby duty — tested monthly, rarely loaded — they typically come out with low hours and documented maintenance. That is exactly what the used market wants.
When your facility upgrades, consolidates, or decommissions, Ironcrest buys used generator sets outright — single units and full fleets. We buy the major makes: Cummins, Caterpillar, Kohler, and Generac, from 100 kW up to multi-megawatt installations.
Sell your generator to Ironcrest → | Call or text 312-880-8174
Typically 100 kVA to 2 MW of standby capacity, sized to the validated critical load — clean rooms, cold storage, and production lines. Many facilities run N+1 configurations so maintenance never drops the load.
Not directly — but FDA/GMP validation makes reliable power effectively mandatory. A power loss can ruin validated batches and cold-chain product, and changes to power systems can trigger IQ/OQ/PQ re-validation. The industry treats standby generation as process-critical.
Diesel dominates for standby duty because of fast start times, on-site fuel storage, and long established service networks. See our diesel vs natural gas generator guide for the full comparison.
On expansions, utility upgrades that would trigger re-validation, site consolidations, and when emissions rules retire older-tier engines. Standby-duty units usually come out with low hours and documented maintenance.
Make, model, kW/kVA rating, hour meter reading, and overall condition — photographed from the nameplate and the unit itself. We buy Cummins, Caterpillar, Kohler, and Generac sets from 100 kW to multi-megawatt, single units and fleets.
Yes — Ironcrest runs nationwide and coordinates rigging, loading, and transport from your facility.
In pharma, power is process protection: clean rooms, cold storage, and validated production lines all ride on standby generation.
New: Explore the Ironcrest Copper Resource Center — grades, markets, identification guides, and interactive tools.
Photograph the material, nameplates and quantity, then send them through the quote form, by email or by phone.
We review what the material is, its condition and quantity, and whether it fits a direct purchase.
For qualifying material, we discuss a direct purchase offer and the next steps.